Purchase of transgenic mice
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- NCTR Acquisition Liaison nctracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is purchasing transgenic mice for a funded research project, with solicitation release estimated for November 1, 2026 and award anticipated January 1, 2027. The requirement specifies immunocompromised huNOG-EXL mice strain with engrafted human immune system, males, age 10–12 weeks, for the Office of Women's Health.
Award value is estimated between $25,000 and $250,000. Inquiries should be directed to the FDA Acquisition Liaison at nctracquisitions@fda.hhs.gov.
Forecast text
Purchase of immunocompromise mice strain huNOG-EXL with engrafted human immune system, males, age 10-12 weeks for FDA (OWH) funded researach project.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast